Renaissance Capital logo

BLACU News

Biotech SPAC Bellevue Life Sciences Acquisition prices $60 million IPO

Bellevue Life Sciences Acquisition, a blank check company backed by Bellevue Capital Management targeting the biotech sector, raised $60 million by offering 6 million units at $10. Each unit consists of one share of common stock, one right to receive one-tenth of a share upon the completion of an initial business combination, and one warrant, exercisable at $11.50. The company is...read more

Biotech SPAC Bellevue Life Sciences Acquisition files for a $60 million IPO

Bellevue Life Sciences Acquisition, a blank check company backed by Bellevue Capital Management targeting the biotech sector, filed on Friday with the SEC to raise up to $60 million in an initial public offering. The Bellevue, WA-based company plans to raise $60 million by offering 6 million units at $10. Each unit consists of one share of common stock and one warrant, exercisable...read more

Archived Headlines